<DOC>
	<DOCNO>NCT00800215</DOCNO>
	<brief_summary>The purpose trial evaluate safety tolerability SPM 927 give iv infusion compare oral administration dose strengths subject receive oral SPM 927 partial seizure without secondary generalization . Trial procedure include medical history update , physical/ neurological exam , ECGs , blood /urine sample collection seizure diary completion . Subjects complete trial return OLE trial resume dose oral SPM 927 .</brief_summary>
	<brief_title>A Trial Investigate Safety , Tolerability Pharmacokinetics Intravenous SPM 927</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Subject partial seizure without secondary generalization Subject previously receive iv SPM 927 Subject meet withdrawal criterion openlabel extension trial SPM 927 experience ongoing serious adverse event .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Epilepsy</keyword>
</DOC>